ABILIFY MAINTENA 720 mg, suspension injectable à libération prolongée en seringue préremplie — 1 seringue préremplie copolymère de cyclooléfines (COC) de 2,4 mL + 2 aiguilles sécurisées
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930289716 -
CIP7
3028971 -
CIS
63466449 -
Registration number
EU/1/13/882
What the source publishes
- Holder
- OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)
- Active ingredients
- ARIPIPRAZOLE
- Form
- suspension injectable à libération prolongée
- Package
- 1 seringue préremplie copolymère de cyclooléfines (COC) de 2,4 mL + 2 aiguilles sécurisées
- Routes
- intramusculaire
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2024-03-25
- Prescription
- Prescription or restricted
Names this record is found by
- ABILIFY MAINTENA 720 mg, suspension injectable à libération prolongée en seringue préremplie — 1 seringue préremplie copolymère de cyclooléfines (COC) de 2,4 mL + 2 aiguilles sécurisées
- ABILIFY MAINTENA 720 mg, suspension injectable à libération prolongée en seringue préremplie
- ARIPIPRAZOLE
Complete source data
{
"cis": "63466449",
"cip7": "3028971",
"form": "suspension injectable à libération prolongée",
"name": "ABILIFY MAINTENA 720 mg, suspension injectable à libération prolongée en seringue préremplie — 1 seringue préremplie copolymère de cyclooléfines (COC) de 2,4 mL + 2 aiguilles sécurisées",
"cip13": "3400930289716",
"holder": "OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)",
"routes": [
"intramusculaire"
],
"holders": [
"OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "369.22",
"authorisedOn": "2024-03-25",
"compositions": [
{
"name": "ARIPIPRAZOLE",
"nature": "SA",
"strength": "720 mg",
"linkageNumber": "1",
"substanceCode": "96835",
"dosageReference": "une seringue préremplie de 2,4 mL",
"pharmaceuticalElement": "suspension"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "368.20",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ABILIFY MAINTENA 720 mg, suspension injectable à libération prolongée en seringue préremplie",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 seringue préremplie copolymère de cyclooléfines (COC) de 2,4 mL + 2 aiguilles sécurisées",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2025-02-06",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ARIPIPRAZOLE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/13/882",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930289716"